Analytics

The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.

LabVantage offers laboratory information management system solutions that include additional industry-specific functionalities.

CEM reports that the EDGE extraction system for rapid sample preparation of gas chromatography/liquid chromatography samples from CEM can prepare samples for molecular analysis within 5 min.

JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D.

The company showcased various updated and new analytical systems and solutions for food analysis and pharmaceutical, clinical research, and materials sciences applications.

New, user-friendly analytical systems provide high-throughput comprehensive characterization and quantitation of small and large molecules.

Shimadzu has added the compact MALDI-8020 for mass spectrometry applications.

New and emerging products advance bio/pharma laboratory operations.

Stability testing on APIs/finished drug product helps define optimal drug packaging for shelf-life storage.

Tableting instruments (i.e., compaction simulators) that simulate high-speed presses can be used in a quality-by-design (QbD) approach to perform in-depth material characterization and direct scale-up.

Can an Irish analytics company and its CEO bring pharma closer to 21st-century practice?

The company aims to add the additional analytical services in the European Union throughout 2018.

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.

A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.

Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.

The company announced the winner of its 2018 Young Chemist Award.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

New technologies, such as NIR and Raman, enable online measurements of blending and content uniformity in the production of solid dosage forms.

X-ray powder diffraction exploits the interaction between x-rays and matter to study the structural and microstructural properties of materials.

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.

Corning will become the exclusive supplier of CytoSMART's new cell counter device that simplifies mammalian cell counting.

Steve Hayward, product marketing manager at BIOVIA, Dassault Systèmes, discusses the importance of both technology and people in the modern laboratory.

This article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.

Regulations and industry guidelines focus on ensuring excipient safety by specifying risk assessments and shared responsibility.

Proposed guidance documents assist drug manufacturers in qualifying single-use systems for commercial drug production.

Cambrex invests in development and laboratory facilities and adds staff.

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.

Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.

Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.